Campioni, M.
Agirrezabal, I.
Hajek, R.
Minarik, J.
Pour, L.
Spicka, I.
Gonzalez-McQuire, S.
Jandova, P.
Maisnar, V.
Funding for this research was provided by:
Amgen Europe GmbH
Article History
Received: 27 March 2018
Accepted: 8 October 2019
First Online: 31 October 2019
Compliance with ethical standards
:
: M Campioni is an employee of Amgen and owns stock in Amgen. I Agirrezabal was an employee of Amgen at the time of the analysis and the manuscript development. R Hajek has received research funding from Amgen, Takeda, Novartis and Janssen; consultancy fees from Amgen, Celgene, Takeda, Bristol-Myers Squibb and Janssen; and honoraria from Amgen, Celgene, Takeda, Bristol-Myers Squibb and Janssen. J Minarik and L Pour declare that they have no conflict of interest. I Spicka has received research funding from Celgene; and honoraria from Amgen, Bristol-Myers Squibb, Celgene, Janssen, Novartis and Takeda. S Gonzalez-McQuire is an employee of Amgen and owns stock in Amgen. P Jandova is an employee of Amgen and owns stock in Amgen. V Maisnar has received research funding from The Binding Site; worked as consultant for Amgen, Bristol-Myers Squibb, Celgene and Takeda; and received honoraria from Janssen.